Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 46

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 46
---
 holder would have been entitled pursuant to the terms of the recapitalization if, immediately prior
to such recapitalization, the holder had been the holder of record of the number of shares then covered by such award. The 2019 Plan also
provides for the adjustment of shares underlying awards previously granted in the event of changes to the outstanding shares by reason
of an extraordinary cash dividend, reorganization, merger, consolidation, combination, split-up, spin-off, exchange or other relevant
change in capitalization occurring after the date of the grant of any award, subject to certain restrictions. In the event of any such
adjustment, the Board of Directors may also adjust the aggregate number of Shares available under the Plan.

| -32- |

Amendment and Termination.

The 2019 Plan shall continue in effect, unless sooner terminated pursuant
to its terms, until the tenth (10) anniversary of the date of Board approval of its amendment and restatement (except as
to awards outstanding on that date). The Board of Directors may terminate the 2019 Plan at any time with respect to any shares for which
awards have not theretofore been granted; provided, however, that the 2019 Plan’s termination shall not materially and adversely
impair the rights of a holder with respect to any award theretofore granted without the consent of the holder. The Board of Directors
shall have the right to alter or amend the 2019 Plan or any part thereof from time to time; provided, however, that without the approval
by a majority of the votes cast at a meeting of our shareholders at which a quorum representing at least 33-1/3% of our shares entitled
to vote generally in the election of directors is present in person or by proxy, no amendment or modification of the 2019 Plan may (i)
materially increase the benefits accruing to holders, (ii) except as otherwise expressly provided in the 2019 Plan, materially increase
the number of shares subject to the 2019 Plan or the individual award agreements, (iii) materially modify the requirements for participation,
or (iv) amend, modify or suspend certain re-pricing prohibitions or amendment and termination provisions as specified therein. In addition,
no change in any award theretofore granted may be made which would materially and adversely impair the rights of a holder with respect
to such award without the consent of the holder (unless such change is required to cause the 2019 Plan